Emerging Infections Program lands national award for COVID response
Jan. 19, 2023—Vanderbilt's Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry.
VUMC-led COVID-19 clinical trial platform goes international
Jan. 5, 2023—The ACTIV-4 Host Tissue clinical trial platform, which is designed to investigate therapies targeting the host tissue response to COVID-19 to mitigate lung injury, is now being expanded internationally.
VUMC strongly recommends COVID-19 bivalent booster vaccination as new COVID-19 variants appear in our region
Jan. 4, 2023—With the development of new variants of the COVID-19 virus across the U.S. and the world, Vanderbilt University Medical Center recommends getting the bivalent booster vaccination.
Bivalent booster vaccine effective in preventing COVID-19 hospitalization in older adults
Dec. 16, 2022—The new bivalent mRNA COVID-19 booster vaccines that began being used in September are beneficial in preventing COVID-19-associated hospitalization in persons 65 and over.
Surgical risk persists for patients who’ve had COVID
Dec. 14, 2022—Vanderbilt researchers report that the trend of decreasing postoperative risk for people who have had COVID persists longer than previously known, for as long as 13 months after COVID.
AstraZeneca VP to discuss COVID-19 collaboration with VUMC Nov. 17
Nov. 10, 2022—On Thursday, Nov. 17, Mark Esser, PhD, vice president, Early Vaccines and Immune Therapies R&D at AstraZeneca, will discuss his company’s collaboration with Vanderbilt University Medical Center that led to development of the Evusheld antibody combo to prevent COVID-19 in high-risk individuals.
CDC health care worker COVID-19 vaccine effectiveness study underway
Nov. 8, 2022—VUMC’s department of Health Policy, in conjunction with the Centers for Disease Control and Prevention (CDC), is working with health care workers to determine the effectiveness of the COVID-19 vaccine in the health care workplace. Emails with a link to a survey will be sent to those who are tested for COVID-19 (the email will...
Study finds Moderna’s COVID-19 vaccine safe and effective for young children
Nov. 4, 2022—A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age.
Event to spotlight VUMC’s COVID-19 research efforts
Nov. 3, 2022—The public is invited to listen in as scientists on the forefront of COVID-19 research at Vanderbilt University Medical Center share their personal stories on Wednesday afternoon, Nov. 16, in 214 Light Hall.
COVID-19 Guideline Revisions & Updates – Important updates to guidelines such as pre-procedure testing and clinical guidelines
Oct. 31, 2022—Several COVID-19 Guidelines have been updated. Here is a summary of the updates with links to revised guidelines on the COVID-19 website. Pre-Procedure Testing Changes: Effective Nov.14, VUMC guidelines for Pre-Procedure Testing will be updated to stop some requirements for preprocedural testing. Revised Guidelines can be found here. Exposure and Return to Work Updated Guidelines:...
Jahangir shares COVID lessons at Reunion Weekend
Oct. 13, 2022—by Bill Snyder As head of Metro Nashville’s COVID-19 Task Force during the height of the pandemic, Vanderbilt orthopaedic trauma surgeon Alex Jahangir, MD, MMHC, witnessed a wide swing of human emotions. Mask mandates, designed to curb the spread of the virus, were met with resistance and outright hostility. Yet many Nashvillians quietly went out...
Cardiologist Brown finds inspiration through music
Oct. 13, 2022—Vanderbilt's Suzanne Brown Sacks, MD, is both a transplant cardiologist and an accomplished singer/songwriter.